~/ Chiefly because of advances in prenatal diagnostic ultrasonography, prognostic data on congenital hydrocephalus have increased in pertinence. Neurosurgeons may be confronted with requests for prognostic information after discovery of gestational hydrocephalus. Because previous reports reflect technical problems, complications, and less favorable results of an evolutionary period in hydrocephalus therapy, the authors have attempted to update the prognostic picture with a review of their results in hydrocephalus that is overt at birth. The status of 37 children treated with cerebrospinal fluid shunts after delivery at term with overt hydrocephalus was evaluated after an average 6-year follow-up period. They represented 8% of all children being followed for hydrocephalus. Outcome was also reviewed in 11 patients with severe hydrocephalus who were not treated. Of treated patients, 86% survived 1 to 16 years, while all of the untreated infants died at an average of 2.5 months. Approximately two-thirds of treated patients have normal or borderline intellectual capabilities (mean IQ 96, standard deviation 22). Dandy-Walker malformation was associated with a high mortality and a very low IQ in survivors. Congenital aqueductal atresia was also associated with intellectual impairment, but children with communicating hydrocephalus and myelomeningocele were not intellectually impaired. Among the survivors with low IQ, the poor outcome was generally predictable on the basis of cortical mantle thickness and "brain mass" calculations before therapy. The findings from this partially selected series indicate that the majority of babies born with overt hydrocephalus have a good prognosis with appropriate therapy.
W
ITH rapid technical advancement in prenatal diagnosis, prognostic information on congenital hydrocephalus has become increasingly important. It is not unusual for neurosurgeons to be confronted with requests for prognostic data by obstetricians who have discovered cases of gestational hydrocephalus with prenatal ultrasonography. 1,3 This role of the neurosurgeon has also been reported by Shapiro and Shulman (The unborn hydrocephalic: the neurosurgeon's role in the care of the infant and mother. Presented at the Interim Meeting, Pediatric Section, American Association of Neurological Surgeons, New York, New York, December, 1980) . Often these findings produce parental despair and raise questions suggesting fetal sacrifice. The poor understanding of the results of cerebrospinal fluid (CSF) shunt therapy derives from a sparse contemporary literature on the subject of congenital hydrocephalus and an apparent lack of timely communication between medical specialists.
In 1973, Mealey, et al.J ~ addressed the subject of prognosis in hydrocephalus overt at birth, reporting 378 on 79 patients, 42 of whom were treated. Among 34 treated with ventriculoatrial (VA) shunts and followed an average of 7 years, 44% survived, and one-third of them had normal intelligence. A large number of the deaths were related to complications of shunting. Recognizing that these results characterized an earlier era in the development of shunt techniques, we consider it pertinent to evaluate and report the results of our own series of comparable size which dates from a later period. Mortality and morbidity have declined considerably during the last decade, as demonstrated by this report. The majority of infants born with overt hydrocephalus have a favorable prognosis with appropriate surgical therapy. We have attempted an evaluation of the quantitative assessment of cranium and brain size in the prediction of outcome.
Clinical Material and Methods
Overt congenital hydrocephalus was defined by head circumference (HC) at birth at or above the 98th percentile (36 cm for girls and 37 cm for boys deliv-27. Neurosurg. / Volume 57 / September, 1982 ered at term). 11 Infants diagnosed with hydrocephalus by air contrast radiography or computerized tomography (CT) and having these measurements comprise 8% of our hydrocephalic children under follow-up review. Premature babies, infants with hydranencephaly, and tumor cases were excluded. The records of these 37 patients were reviewed for data on the thickness of cortical mantle (ventricle-skull distance (VSD)) at the time of diagnostic studies, and computations were performed for "brain mass," a constructional method described by Shurtleff, et ler Intelligence Scale for Children-Revised (WISC-R). Academic placement was recorded for 18 children who had reached school age.
The characteristics of a group of 11 infants born with hydrocephalus but not surgically treated were similarly assessed for HC, VSD, brain mass, associated anomalies, and age at death.
Statistical comparisons were performed to analyze severity of hydrocephalus before therapy (expressed as VSD or brain mass as a percent of the normal mean for age) between survivors with normal intelligence and retardation and those who died under treatment. These comparisons were intended to determine predictive factors that might be of value in future parental counseling and therapeutic planning. Table 1 depicts the range and mean HC, VSD, brain mass, and length of survival as well as associated congenital anomalies in 11 untreated patients. Scant perinatal data were available. Mean HC was similar to HC in intellectually impaired treated survivors, but VSD and brain mass averaged 0.5 cm and 123 (28% normal mean for age), respectively, which was less than in the treated patients (Table 2 ). In fact, brain mass averaged considerably less than the second percentile ( Fig. 1) . All but three of the untreated patients had extensive myelodysplasia, one had an occipital encephalocele, and another suffered perinatal asphyxia. With one exception, all were kept in hospitals and were fed, nursed, and given anticonvulsant therapy as necessary. No antibiotics or surgery were employed. The primary causes of death were respiratory infections and purulent meningoencephalitis. All of these patients died between 2 weeks and 16 months (average survival 2.5 months) after birth.
Results
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Preoperative Clinical Features. Table 2 describes the etiology or sites of CSF block and other clinical findings in the 37 infants. Mean VSD and brain mass were higher than measured in the untreated group, but HC difference was slight (Table 3) . Although vaginal deliveries were common, only two were described as complicated or difficult, and only one of these was associated with perinatal asphyxia. Nearly 50% had associated anomalies of the central nervous system, but myelodysplasia was rarely associated with overt hydrocephalus at birth except in the more extreme cases described in the series of untreated patients.
Follow-Up Time and Survival Mean length of follow-up observation was 6 years (range 1 to 16 years) among patients originally treated with shunts at a mean age of 11 weeks (range 1 to 120 weeks, median 4 weeks). There were five deaths, producing an 86% D. C. McCullough and L. A. Balzer-Martin survival. All deaths occurred in patients with either Dandy-Walker cyst or aqueductal atresia (Table 4) .
Shunt Revisions. Although 31 ventriculoperitoneal (VP) and six VA shunts were originally inserted, all but one of the survivors currently have functioning VP devices. One child survives in good condition, with an intelligence quotient (IQ) of 90, after shunt removal, but the others are suspected to be shuntdependent on the basis of serial digital examination of shunt reservoirs, CT scans, and periodic symptoms that require shunt revisions. Twenty-two of the 37 patients have had a total of 56 shunt revisions, giving a composite revision rate of 1.5 per patient. Table 7 shows the breakdown for survivors.
Intellect Related to Etiology and Brain Mass. Table  5 subdivides survivors according to etiology or site of CSF block, demonstrating a clear relationship between cause and outcome. Selected patients with myelodysplasia and children with congenital communicating hydrocephalus represent a high-IQ group and, although VSD and brain mass measurements were only slightly lower for patients with aqueductal blocks, mean IQ fell into the borderline category for the latter group. Three of the six patients with DandyWalker malformation died, and the three survivors with this disease have serious intellectual handicaps, perhaps reflecting extremely low VSD and brain mass at birth. The only child in the series with perinatal asphyxia and neonatal seizures was one of the group with aqueductal atresia. He survives in a severely retarded condition. Table 6 shows the influence of all of the diagnosed central nervous system anomalies with respect to later performance.
Intellect, Head Size, VSD, and Brain Mass. To evaluate the predictive accuracy of the HC, VSD, and brain mass, a retrospective analysis of these measurements was constructed in comparison to intelligence in survivors (Table 7 and Fig. 1 ). A clear relationship between a large HC at birth, small VSD, and limited brain mass, on the one hand, and impaired intelligence on the other, attests to a general predictive value for these measurements, but only the VSD Age at Therapy. In contrast to earlier reports, 11Az we found little relationship between prompt therapy and improved performance. Although 11 patients treated at less than 1 month of age had a mean IQ of 90.5, three treated after 6 months of age had a mean IQ of 112. Those treated at 2 months were more accomplished than those treated at 1, 3, and 4 months, respectively.
Performance Versus Shunt Revisions, Infections, and Complications. The number of revisions was higher for the group with normal intellect (1.8 per patient with IQ > 80) than the subnormal groups (1.4 per patient with IQ < 80), but the former group was an average of 1.3 years older. Four of the survivors experienced shunt infections. Although three of them are essentially vegetative, they were obviously severely impaired before the infections were acquired, and additional cerebral injury is conjectural. The fourth patient is in a regular school at age 15 years, with an IQ of 85, 6 years after her infectious episode. Subdural effusions necessitated valve revisions and temporary subdural-peritoneal shunting in three children, all of whom are currently in the normal IQ category.
Discussion
This review was inspired by experience in counseling parents referred for discussion of the implications of hydrocephalus discovered in utero. From initial provision of crude measurements of cranial biparietal diameter, prenatal ultrasonic imaging has been developed to the point of offering calculated head circumferences and measurements of VSD with plotted percentile curves reflecting progression at various gestational ages? In addition, a variety of associated central nervous system and systemic anomalies may be detected. In such cases, most parents have been presented with a grim prognosis based on cursory reviews of published materials or particular opinions of obstetricians and pediatricians. Some parents have rejected their unborn child outright after being informed of the ultrasonic findings. Others have inquired about antenatal therapy 1 or early delivery to facilitate prompt treatment of the condition. Under these circumstances, the importance of timely prognostic data became obvious. A major exigency is for data pertaining to patients treated by conventional surgical methods that have evolved over the past two decades. Laurence and Coates 7,s provided the standard for the natural history of patients demonstrating clinically recognized hydrocephalus throughout the childhood years, thus including cases of acquired hydrocephalus. Among the 46% who survived up to 20 years, the majority were thought to have undergone spontaneous arrest, but only 38% had normal intellect. 7,s Yashon, et al., TM reported a similar outcome in untreated cases and a very high mortality for children treated by a variety of surgical procedures before the introduction of valve shunting systems. After resorting to ventriculovenous bypass, they reported a 70% "success rate" or short-term survival. 15 Others demonstrated a similar improvement in the rate of salvage. ~ Current reviews of all types of pediatric hydrocephalus reflect a declining mortality rate, and a 50% to 70% incidence of normal intelligence. 6,'2,17 Lorber and Zachary 9 reported that 83% of treated congenital hydrocephalic patients achieve a 7-to 9-year survival, and 84% reach normal intelligence, but apparently only a few of their patients exhibited macrocephaly at birth. Dennis, et al., 4 have recently shown generally lower full-scale IQ's and significant discrepancies between verbal and performance scores for cases with congenital hydrocephalus compared with acquired cases.
Our interest here is in the outlook for children born at term with external evidence of hydrocephalus. Although such patients represent a distinct minority of children with the disorder, the results of therapy in this group are the only pertinent statistics applicable in counseling parents and physicians who have encountered intrauterine or newborn babies with hydrocephalus. To our knowledge, the only specific historical guideline is the 1973 report of Mealey, et aL, 1~ of a series similar to ours in size, length of follow-up study, sites of CSF blocks, and head sizes. There were more Caesarean deliveries in our series but, considering the comparable incidence of neonatal distress, this does not appear to have influenced survival status. Among our treated patients, the figures for survival (86%), normal intelligence (53%), and per-patient shunt revision rate (1.5) compared with the 44%, 30%, and 2.2, respectively, reported by Mealey, et al., do reflect the increased capabilities achieved over the last decade.
Conflicting evidence exists concerning the influence of ventricular size on outcome.'2,'3 The severity of the disorder has been graded with a variety of scales, z,~,12 including the theoretical construction, brain mass, which we used to estimate the interrelationship between magnitude of hydrocephalus and later intellectual performance. We found that in a crude sense the brain mass and VSD predict outcome (Fig. 1) , but significant exceptions dictate cautious application of these measures in recommending against therapy. Dennis, et al., 4 have evaluated selected children with infantile-onset hydrocephalus and IQ scores above 70 in a comprehensive study of patterns of D. C. McCullough and L. A. Balzer-Martin intelligence compared with early developmental status, symptoms, cerebral abnormalities, and therapeutic factors. Their population differed from our purely congenital hydrocephalic patients who were unselected for IQ levels, but some common features exist between the two groups. For example, performance IQ scores were skewed toward lower values in spite of full-scale and verbal IQ's of 90 to 110. We found similar discrepancies in our patients, and likewise noted performance and full-scale deficits among children with ocular system and motor disabilities. Although lower performance and full-scale IQ's were characteristic of their normal-IQ patients with seizures, 4 we found a history of seizures in only one of our normal-IQ children and in eight of the retarded or deceased group, illustrating some dissimilarities between their patient population and ours.
No difference in patterns of intelligence was found between communicating and noncommunicating hydrocephalics by Dennis, et aL, 4 but they disclosed a verbal-performance discrepancy consistent with anterior third ventricle or aqueductal obstruction which seems roughly prophetic of the gross full-scale IQ deficiency among our infants with noncommunicating hydrocephalus, 82% of whom had aqueductal atresia. We have not analyzed regional or global cortical thinning in relationship to specific patterns of intelligence of our normal-IQ survivors, recognizing that such precision may not be realistic in attempting to "fine tune" prognostic data for counseling purposes in gestational hydrocephalus.
Based on these data, our advice in counseling parents and obstetricians is that the baby should be carried as near to term as possible, delivered by the safest obstetrical method (usually Caesarean section), and carefully evaluated after delivery. We believe that the infant should be treated except in extreme instances (severe birth defects and minimal cerebral tissue) and should have at least an 85% chance of survival with a 72% probability of normal (53% probability of an IQ over 80) or borderline (19% probability of an IQ 65 to 80) intellect. Morbidity and mortality may be expected to be higher in cases of Dandy-Walker malformation and aqueductal atresia, and lower in communicating hydrocephalus. With few exceptions, the shunt device will have to be maintained for the lifetime of the patient.
